Andy Yao, BSc

I am an experienced clinical data manager with over nine years of expertise spanning contract research organizations and academic clinical research. My work has focused on the end-to-end delivery of high-quality clinical trial data, with particular focus in vaccines, infectious diseases, and neuromuscular rare diseases research.

I began my career in a CRO environment, where I developed a strong foundation in clinical data management across early- and late-phase trials. I lead multiple vaccine studies with NIH and NIAID, including Phase 1–3 trials in areas such as E. coli, Norovirus, and other gastrointestinal pathogens.

In 2019, I moved to the University of Oxford, where I played a key role in several high-profile vaccine trials, including the Oxford–AstraZeneca COVID-19 vaccine program. As a lead data manager, I supported rapid study start up and execution under unprecedented timelines, contributing to one of the most impactful global clinical research efforts in recent history.

I currently serve as the data manager STRONG, focused on neuromuscular rare diseases. In this role, I have built the data management function, establishing infrastructure, standard operating procedures, and scalable processes to support a diverse portfolio of studies.

Beyond operational delivery, I have a strong interest in advancing clinical data management through the thoughtful adoption of new technologies. I have contributed to initiatives involving data federation and secure multi-party computation, aimed at improving data sharing and collaboration in rare disease research while maintaining strict regulatory compliance.

I enjoy collaborative approach, working closely with statisticians, clinicians, and regulatory teams to ensure that data collection aligns with study objectives and downstream analysis needs. I combine technical expertise with strong communication skills, enabling myself and my team to effectively bridge gaps between disciplines and support high-quality clinical research outcomes.